Fiona Hunter

Fiona Hunter

Auto-generated profile, based on publicly available information

Fiona Hunter

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DMDavid Mendez
David Mendez
AGAnna Gaulton
Anna Gaulton
ABA Patrícia Bento
A Patrícia Bento
JCJon Chambers
Jon Chambers
MVMarleen De Veij
Marleen De Veij
ALAndrew R Leach
Andrew R Leach
ChEMBL is a large, open-access bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012, 2014 and 2017 Nucleic Acids Research Database Issues. In the last two years, several important improvements have been made to the database and are described here. These include more robust capture and representation of assay details; a new data deposition system, allowing updating of data sets and deposition of supplementary data; and a completely redesigned web interface, with enhanced search and filtering capabilities.

23 October 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AMAlex L Mitchell
Alex L Mitchell
MSMaxim Scheremetjew
Maxim Scheremetjew
HDHubert Denise
Hubert Denise
SPSimon Potter
Simon Potter
ATAleksandra Tarkowska
Aleksandra Tarkowska
RFRobert D Finn
Robert D Finn
EBI metagenomics (http://www.ebi.ac.uk/metagenomics) provides a free to use platform for the analysis and archiving of sequence data derived from the microbial populations found in a particular environment. Over the past two years, EBI metagenomics has increased the number of datasets analysed 10-fold. In addition to increased throughput, the underlying analysis pipeline has been overhauled to include both new or updated tools and reference databases. Of particular note is a new workflow for taxonomic assignments that has been extended to include assignments based on both the large and small subunit RNA marker genes and to encompass all cellular micro-organisms. We also describe the addition of metagenomic assembly as a new analysis service. Our pilot studies have produced over 2400 assemblies from datasets in the public domain. From these assemblies, we have produced a searchable, non-redundant protein database of over 50 million sequences. To provide improved access to the data stored within the resource, we have developed a programmatic interface that provides access to the analysis results and associated sample metadata. Finally, we have integrated the results of a series of statistical analyses that provide estimations of diversity and sample comparisons.

1 December 2012 in Mineralogical Magazine
Verified
Journal Article
Open access
GBG. M. N. Baston
G. M. N. Baston
ACA. P. Clacher
A. P. Clacher
THT. G. Heath
T. G. Heath
FHF. M. I. Hunter
F. M. I. Hunter
VSV. Smith
V. Smith
SSS. W. Swanton
S. W. Swanton
A cementitious backfill has been proposed in many geological disposal concepts for intermediate-level waste and low-level waste in the UK and elsewhere. In this paper, the main features of the chemical evolution of backfill and the associated changes in the near-field pH are illustrated with results from recent work. For example, interaction of the groundwater with calcium silicate hydrate (C-S-H) phases in a backfill is expected to play an important role in the long-term pH-buffering behaviour. Existing experimental data for the dissolution of C-S-H gels are compared with recent experimental results from leach tests on gels of a lower calcium to silicon ratio (C/S) to provide a consistent set of data across the full C/S range. The results confirm that a congruent dissolution point around C/S = 0.8 is approached by leaching from below (i.e. for gels with 0.29 < C/S < 0.8), as well as from above, as reported elsewhere. In addition, a spreadsheet model has been developed to calculate the volume of backfill required at the vault scale to meet specified pH performance criteria. This model includes the major reactions of the backfill with the groundwater, waste encapsulants and waste components. It can also consider the effects of specific waste packages on local pH performance to allow comparison with the vault-scale calculations.

15 October 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
NSNathalie Selevsek
Nathalie Selevsek
FCFlorian Caiment
Florian Caiment
RNRamona Nudischer
Ramona Nudischer
HGHans Gmuender
Hans Gmuender
IAIrina Agarkova
Irina Agarkova
JKJos Kleinjans
Jos Kleinjans
Uncovering cellular responses from heterogeneous genomic data is crucial for molecular medicine in particular for drug safety. This can be realized by integrating the molecular activities in networks of interacting proteins. As proof-of-concept we challenge network modeling with time-resolved proteome, transcriptome and methylome measurements in iPSC-derived human 3D cardiac microtissues to elucidate adverse mechanisms of anthracycline cardiotoxicity measured with four different drugs (doxorubicin, epirubicin, idarubicin and daunorubicin). Dynamic molecular analysis at in vivo drug exposure levels reveal a network of 175 disease-associated proteins and identify common modules of anthracycline cardiotoxicity in vitro, related to mitochondrial and sarcomere function as well as remodeling of extracellular matrix. These in vitro-identified modules are transferable and are evaluated with biopsies of cardiomyopathy patients. This to our knowledge most comprehensive study on anthracycline cardiotoxicity demonstrates a reproducible workflow for molecular medicine and serves as a template for detecting adverse drug responses from complex omics data.

19 September 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
FHFiona M. I. Hunter
Fiona M. I. Hunter
HIHarris Ioannidis
Harris Ioannidis
ABA. Patrícia Bento
A. Patrícia Bento
NBNicolas Bosc
Nicolas Bosc
SCSybilla Corbett
Sybilla Corbett
ALAndrew R. Leach
Andrew R. Leach
ChEMBL is a large-scale, open-access, FAIR database of bioactive molecules with drug-like properties. ChEMBL 35 contains 17,500 approved drugs, and drugs that are progressing through the clinical development pipeline. Drug curation has formed an integral part of the core offering of the ChEMBL database since its inception. The paper is a reference guide to present the principles of why the ChEMBL drug data has been curated in a particular manner so that data users can better understand the nature of the data. The drug data include information on: names, synonyms and trade names, chemical structure or biological sequence, data sources, indications, mechanisms, warnings and drug properties such as maximum phase of development, type of molecule, prodrug status and first approval. The integrated nature of the drug data within the context of a bioactivity resource enables the wide use of the data set in drug discovery, AI and machine learning.

28 January 2021 in Chemical Research in Toxicology
Verified
Journal Article
Open access
FHFiona M.I. Hunter
Fiona M.I. Hunter
ABA. Patrícia Bento
A. Patrícia Bento
NBNicolas Bosc
Nicolas Bosc
AGAnna Gaulton
Anna Gaulton
AHAnne Hersey
Anne Hersey
ALAndrew R. Leach
Andrew R. Leach
The safety of marketed drugs is an ongoing concern, with some of the more frequently prescribed medicines resulting in serious or life-threatening adverse effects in some patients. Safety-related information for approved drugs has been curated to include the assignment of toxicity class(es) based on their withdrawn status and/or black box warning information described on medicinal product labels. The ChEMBL resource contains a wide range of bioactivity data types, from early “Discovery” stage preclinical data for individual compounds through to postclinical data on marketed drugs; the inclusion of the curated drug safety data set within this framework can support a wide range of safety-related drug discovery questions. The curated drug safety data set will be made freely available through ChEMBL and updated in future database releases.